Pnömoni tanısıyla değerlendirilen çocuk hastaların kardiyolojik bulguları

Amaç: Pnömoniler önemli bir sağlık sorunudur. Hastalığın seyrinde kardiyovasküler sisteme ait değişik düzeyde etkilenmeler görülebilir. Bu çalışmayla toplum kökenli pnömoni tanısı konulan çocuk hastaların değerlendirilmesi amaçlanmıştır.Gereç ve Yöntem: Bir ay–16 yaş arası çocuklar prospektif olarak değerlendirilmiş, bu hastaların bazı klinik, laboratuvar, radyolojik ve ekokardiyografik bulguları araştırılmıştır. Ayrıca altta yatan kalp-dışı kronik hastalığı olan hastalarla, olmayanlar karşılaştırılmıştır.Bulgular: Hastaların ortanca yaşı 32 aydı. Kırksekiz (%76.2) hasta yatırılarak izlendi. Hastaların yaklaşık dörtte birinde konjenital kalp hastalığı mevcuttu. Bu hastaların 5’inde (%31.2) kalpte hemodinamik instabilite oluşturan yapısal defekt varken, 11’inde (%68.7) hemodinamik önemi olmayan yapısal lezyonlar mevcuttu. Ondört (%22.2) hastada triküspit yetmezliği, 10 (%15.9) hastada değişik derecelerde pulmoner hipertansiyon saptandı. Hastaların üçte birinde tekrarlayan akciğer enfeksiyonu bildirildi. Onsekiz (%28.6) hastada kalp-dışı kronik hastalık mevcuttu. Hastaların akciğer grafilerinde çoğunlukla lober tutulum (%49.2) gözlendi. Dörtte bir hastada akciğerlerde pnömoniye bağlı komplikasyon gözlenirken, bunların çoğunluğu parapnömonik efüzyondu. Altta yatan kalp-dışı kronik hastalığı olan hastaların, tekrarlayan akciğer enfeksiyonu geçirme, ekokardiyografide triküspit yetmezliği ve pulmoner hipertansiyon bulunma ve hospitalizasyon oranlarının, kronik hastalığı olmayanlara göre daha yüksek olduğu saptandı.Sonuç: Pnömoniler önemli kardiyak komplikasyonlara yol açabilmektedir. Altta yatan non-kardiyak bir kronik hastalığın varlığı, pnömoninin hem rekürens riskini hem de morbiditesini artırmaktadır.

Cardiological findings of pediatric patients with the diagnosis of pneumonia

Purpose: Pneumonia is an important health problem. Cardiovascular system is involved variously during course of disease. This study aims to investigate children with community-acquired pneumonia.Material Methods: Children aged one month-16 years were prospectively evaluated about some of their clinical, laboratory, radiological, and echocardiographical findings. Also, children with non-cardiac chronic diseases were compared with children having no chronic disease. Results: Median age of patients was 32 months. Fortyeight (76.2%) patients were hospitalized. One fourth of children had congenital heart disease. Among these, 5 (31.2%) had hemodynamically instable cardiac defect, while 11 (68.7%) had hemodynamically insignificant cardiac lesions. Tricuspid insufficiency was present in 14, various degrees of pulmonary hypertension were present in 10 (15.9%) patients. One third reported recurrent pulmonary infections. Eighteen (28.6%) patients had non-cardiac chronic diseases. Mostly lobar infiltration (49.2%) was present. One quarter had pulmonary complications, most of which were parapneumonic effusion. Patients with non-cardiac chronic diseases had more prevalent recurrent pulmonary infections, tricuspid insufficiency and pulmonary hypertension, and hospitalization than children having no chronic disease.Conclusion: Serious cardiac complications can be encountered during course of pneumonia. Presence of an underlying non-cardiac chronic disease increase both recurrence and morbidity of pneumonia. 

___

  • 1. World Health Organization. Pneumonia. Fact sheet No. 331. 2009. Available from http://www.who.int/mediacentre/factsheets/fs331/ en/index.html (accessed May 2016).
  • 2. Das A, Patgiri SJ, Saikia L, Dowerah P, Nath R. Bacterial pathogens associated with communityacquired pneumonia in children aged below five years. Indian Pediatr. 2016;53:225-7.
  • 3. Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 2004;113:701–7.
  • 4. Kocabaş E, Doğru Ersöz D, Karakoç F, Tanir G, Cengiz AB, Gür D et al. Türk Toraks Derneği çocuklarda toplumda gelişen pnömoni tanı ve tedavi uzlaşı raporu. Türk Toraks Dergisi. 2009;S3:1-24.
  • 5. Salnikova LE, Smelaya TV, Moroz VV, Golubev AM, Rubanovich AV. Host genetic risk factors for community-acquired pneumonia. Gene. 2013;518:449-56.
  • 6. Lee GE, Lorch SA, Sheffler-Collins S, Kronman MP, Shah SS. National hospitalization trends for pediatric pneumonia and associated complications. Pediatrics. 2010;126:204-13.
  • 7. Corrales-Medina VF, Musher DM, Shachkina S, Chirinos JA. Acute pneumonia and the cardiovascular system. Lancet. 2013;381:496–505.
  • 8. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53:e25-76.
  • 9. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30:2493-537.
  • 10. Kumar R, Wallace WA, Ramirez A, Benson H, Abelmann WH. Hemodynamic effects of pneumonia. II. Expansion of plasma volume. J Clin Invest. 1970;49:799-805.
  • 11. Benson H, Akbarian M, Adler LN, Abelmann WH. Hemodynamic effects of pneumonia. I. Normal and hypodynamic responses. J Clin Invest. 1970;49:791– 98.
  • 12. Brown AO, Millett ER, Quint JK, Orihuela CJ. Cardiotoxicity during invasive pneumococcal disease. Am J Respir Crit Care Med. 2015;191:739-45.
  • 13. Light RB. Pulmonary pathophysiology of pneumococcal pneumonia. Semin Respir Infect. 1999;14:218–26.
  • 14. Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM. Azithromycin and the risk of cardiovascular death. N Engl J Med. 2012;366:1881-90.
  • 15. Çelebi S, Hacımustafaoğlu M, Albayrak Y, Bulur N. Çocuklarda tekrarlayan pnömoni. Çocuk Enf Derg. 2010;4:56-9.
  • 16. Mani CS, Murray DL. Acute pneumonia and its complications. In Principles and Practice of Pediatric Infectious Disease, 4th ed (Eds SS Long, LP Pickering, CG Prober): 235-45. Pennsylvania, Churchill Livingstone, 2012.
  • 17. Nohynek H, Valkeila E, Leinonen M, Eskola J. Erythrocyte sedimentation rate, white blood cell count and serum C-reactive protein in assessing etiologic diagnosis of acute lower respiratory infections in children. Pediatr Infect Dis J. 1995;14:484–90.
  • 18. Krenke K, Urbankowska E, Urbankowski T, Lange J, Kulus M. Clinical characteristics of 323 children with parapneumonic pleural effusion and pleural empyema due to community acquired pneumonia. J Infect Chemother. 2016;22:292-7.
  • 19. Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med. 2013;369:155–63.
Cukurova Medical Journal-Cover
  • ISSN: 2602-3032
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1976
  • Yayıncı: Çukurova Üniversitesi Tıp Fakültesi